We use cookies to collect information about how you use our site.
We use this information to make the website work as well as possible and improve our services.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you accept.
Angela Crosby, Antenatal and Newborn Screening Coordinator, United Lincolnshire Hospitals NHS Trust (ULHT), talks about the role of her team and the impact genomics has in their work.
Anita Murphy, regional Genetic Diabetes Nurse, highlights why this type of diabetes should be considered when patients are seen.
We are one of seven hubs within England which make up the national genomic laboratory service
Set up to ensure all eligible patients across the East Midlands and East of England can access and benefit from appropriate genomic tests
Find out more about our tests for rare and inherited diseases, cancer, and haematological malignancy
If you know which test you want to order and how to order it, this link will direct you to the forms you need.
An appropriate discussion of genomic testing must take place before testing is requested.
Find out about courses as well as well as career options within genomics
For Diabetes Week (13 - 19 June), Anita Murphy, our regional Genetic Diabetes Nurse - East Midlands and East of England - has shared with us why it is important for clinicians to consider this type of diabetes when seeing patients and how it can change th
The recently appointed nursing and midwifery staff at East Genomics are an essential part of the strategic team to support the mainstreaming of genomic medicine into clinical practice across the East of England and East Midlands to help improve patient care and outcomes.
In a significant milestone, more than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing (WGS) and interpreted by scientists in the NHS Genomic Medicine Service at Cambridge University Hospitals NHS Foundation Trust (CUH), to help improve their diagnosis and treatment.
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of over 50 new potential causes of cancer.
Brain tumour patients at Addenbrooke’s Hospital in Cambridge are the first in the UK to benefit from personalised treatment using the latest advances in genomics and targeted therapies through the Minderoo Foundation's new Precision Brain Tumour Programme (MPBTP).